Brief: Editas Medicine Q3 Net Income USD -25.117 Million Vs. IBES Estimate USD -28.1 Million
10/11/2025 12:00
Nov 10 (Reuters) - Editas Medicine Q3 operating expenses USD 32.091 million. Q3 basic EPS USD -0.28 Q3 operating income USD -24.548 million Q3 EPS USD -0.28 Q3 collaboration and other research and development revenue USD 7.5 million
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering